Emmessar Biotech & Nutrition Ltd (EMMESSA) is currently trading at 26.36 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Emmessar Biotech & Nutrition Limited is a Mumbai‑based specialty chemicals turned healthcare and nutraceutical company, manufacturing fine chemicals, nutraceuticals and cosmeceuticals while also deriving significant recurring income from rent on leasehold land. The company reported consolidated income of INR 184.06 lakhs for the nine months ended December 31, 2025, with Profit Before Tax of INR 50.00 lakhs and reported basic earnings per share of INR 0.80 for the same period, reflecting profitable operations despite modest absolute scale. Operationally Emmessar splits activity across Healthcare, Rent on Leasehold Land and Other segments; nine‑month segment revenue split shows Rent on Leasehold Land as the largest contributor at INR 123.98 lakhs, indicating material non‑manufacturing income that supports overall cash flows. R&D and product strategy remain central: the company has DSIR recognition for its R&D, a long standing collaboration with California’s Vibrant Life, and has developed the VedaCeuticals concept combining nutraceuticals, Ayurveda and nanotechnology, signaling deliberate innovation-driven positioning within niche health markets. Management asserts compliance and governance discipline with Audit Committee review and limited review by statutory auditors; the company also notes labour code developments but currently assesses no material impact, indicating active regulatory monitoring and conservative disclosure practices.

Over the past 52 weeks, Emmessar Biotech & Nutrition Ltd has traded between a low of ₹18.42 and a high of ₹33.38. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Emmessar Biotech & Nutrition Ltd has a market capitalization of approximately 13.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Emmessar Biotech & Nutrition Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 32.86 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 13.80 Cr, Emmessar Biotech & Nutrition Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Emmessar Biotech & Nutrition Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Emmessar Biotech & Nutrition Ltd is 32.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.